+

NO20071937L - Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer - Google Patents

Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer

Info

Publication number
NO20071937L
NO20071937L NO20071937A NO20071937A NO20071937L NO 20071937 L NO20071937 L NO 20071937L NO 20071937 A NO20071937 A NO 20071937A NO 20071937 A NO20071937 A NO 20071937A NO 20071937 L NO20071937 L NO 20071937L
Authority
NO
Norway
Prior art keywords
preparation
protease inhibitors
intermediates
methods
cysteine protease
Prior art date
Application number
NO20071937A
Other languages
English (en)
Norwegian (no)
Inventor
Jiayao Li
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20071937L publication Critical patent/NO20071937L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/16Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • C07D213/34Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
NO20071937A 2004-09-17 2007-04-16 Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer NO20071937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61080604P 2004-09-17 2004-09-17
PCT/US2005/033051 WO2006034004A2 (fr) 2004-09-17 2005-09-16 Procedes et produits intermediaires permettant de preparer des inhibiteurs de la cysteine protease

Publications (1)

Publication Number Publication Date
NO20071937L true NO20071937L (no) 2007-06-15

Family

ID=35899659

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071937A NO20071937L (no) 2004-09-17 2007-04-16 Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer

Country Status (15)

Country Link
US (1) US7737300B2 (fr)
EP (1) EP1799645A2 (fr)
JP (1) JP2008513472A (fr)
KR (1) KR20070061877A (fr)
CN (1) CN101068783A (fr)
AU (1) AU2005287046A1 (fr)
BR (1) BRPI0515470A (fr)
CA (1) CA2580065A1 (fr)
CR (1) CR8993A (fr)
EC (1) ECSP077321A (fr)
IL (1) IL181792A0 (fr)
MX (1) MX2007003118A (fr)
NO (1) NO20071937L (fr)
WO (1) WO2006034004A2 (fr)
ZA (1) ZA200703102B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004274471A1 (en) 2003-09-18 2005-03-31 Virobay, Inc. Haloalkyl containing compounds as cysteine protease inhibitors
JP5154944B2 (ja) 2004-12-02 2013-02-27 ビロベイ,インコーポレイティド システインプロテアーゼインヒビターとしてのスルホンアミド含有化合物
KR101447897B1 (ko) 2005-03-21 2014-10-07 비로베이, 인코포레이티드 시스테인 단백질분해효소 억제제로서의 알파 케토아미드화합물
CA2602112A1 (fr) 2005-03-22 2006-09-28 Celera Genomics Composes contenant du sulfonyle en tant qu'inhibiteurs de cysteine proteases
WO2008028301A1 (fr) * 2006-09-08 2008-03-13 Merck Frosst Canada Ltd. Promédicaments d'inhibiteurs de la cathepsine s
US20100048717A1 (en) * 2006-09-25 2010-02-25 MERCK FROSST CANADA LTD, Merk & Co., Inc. Cathepsin b inhibitors
MX2009003563A (es) 2006-10-04 2009-04-15 Virobay Inc Compuestos que contienen di-fluoro como inhibidores de proteasa de cisteina.
US7893112B2 (en) 2006-10-04 2011-02-22 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
WO2008070994A1 (fr) 2006-12-14 2008-06-19 Nps Pharmaceuticals, Inc. Utilisation de dérivés de la d-sérine pour le traitement de troubles de l'anxiété
WO2008119176A1 (fr) 2007-04-02 2008-10-09 Merck Frosst Canada Ltd. Procédé d'amidation pour la préparation d'inhibiteurs de la cathepsine k
KR101286323B1 (ko) 2008-10-17 2013-07-15 제논 파마슈티칼스 인크. 스피로-옥스인돌 화합물 및 치료제로서의 그의 용도
WO2010148488A1 (fr) * 2009-06-22 2010-12-29 Merck Frosst Canada Ltd. Inhibiteurs de la cathepsine cystéine protéase pour traiter des maladies variées
US8324417B2 (en) 2009-08-19 2012-12-04 Virobay, Inc. Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof
WO2012119941A1 (fr) 2011-03-04 2012-09-13 Prozymex A/S Composés de peptidylnitrile à titre d'inhibiteurs de peptidases
US20120329837A1 (en) * 2011-06-17 2012-12-27 Virobay, Inc. Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system
CN106478564B (zh) * 2015-08-29 2021-11-12 广东东阳光药业有限公司 组织蛋白酶k抑制剂及其用途
WO2017036357A1 (fr) * 2015-08-29 2017-03-09 广东东阳光药业有限公司 Inhibiteur de cathepsine k et son application
US20220193048A1 (en) 2019-04-05 2022-06-23 Universite De Bretagne Occidentale Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK6572000A3 (en) * 1997-11-05 2000-10-09 Novartis Ag Dipeptide nitriles, process for the preparation thereof, their use as medicaments and pharmaceutical composition comprising them
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
EP1155010A1 (fr) * 1999-02-20 2001-11-21 AstraZeneca AB Derives acetamido acetonitriles en tant qu'inhibiteurs de la cathepsine l et/ou s
US6936606B2 (en) * 2001-10-02 2005-08-30 Boehringer Ingelheim Pharmaceuticals, Inc. Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
DK1482924T3 (da) * 2002-03-05 2008-09-29 Merck Frosst Canada Ltd Cathepsin-cystein-protease-inhibotorer
JP4076955B2 (ja) * 2002-03-11 2008-04-16 花王株式会社 化粧料

Also Published As

Publication number Publication date
EP1799645A2 (fr) 2007-06-27
IL181792A0 (en) 2007-07-04
JP2008513472A (ja) 2008-05-01
WO2006034004A2 (fr) 2006-03-30
ZA200703102B (en) 2009-09-30
BRPI0515470A (pt) 2008-07-22
ECSP077321A (es) 2007-04-26
MX2007003118A (es) 2007-05-24
US20080114175A1 (en) 2008-05-15
CR8993A (es) 2007-10-04
CN101068783A (zh) 2007-11-07
KR20070061877A (ko) 2007-06-14
WO2006034004A3 (fr) 2006-11-23
AU2005287046A1 (en) 2006-03-30
CA2580065A1 (fr) 2006-03-30
US7737300B2 (en) 2010-06-15

Similar Documents

Publication Publication Date Title
NO20071937L (no) Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer
EA200970050A1 (ru) Ингибиторы пролилгидроксилаз
EA200601795A1 (ru) Синтез эфиров бороновой кислоты и кислотных соединений
TW200716525A (en) Process for preparation of sulfamide derivatives
CY1114916T1 (el) Μεθοδοι
EA200970680A1 (ru) N-замещенные производные глицина: ингибиторы гидроксилаз
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
NO20071604L (no) Loxapinanaloger og fremgangsmater for anvendelse derav.
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
HRP20080554A2 (en) Process for preparation of hiv protease inhibitors
TW200603823A (en) Novel use of peptide compounds for treating essential tremor and other tremor syndromes
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
NO20065297L (no) Anvendelse av GPCR54 ligander til behandling av infertilitet
NO20082749L (no) Fremgangsmate for fremstilling av ferri-succinylkasein
DK1499213T3 (da) Tandrengöringsanordning
EA200601358A1 (ru) Новые ингибиторы химазы
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
DE602005012097D1 (de) Adjuvante zusammensetzung und anwendungsverfahren dafür
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20080661L (no) Nye cystein-protease-inhibitorer og deres terapeutiske anvendelser
EA200800411A1 (ru) Новая кристаллическая форма периндоприлэрбумина
NO20072431L (no) Fremgangsmate og intermediater for fremstilling av N-(1-benzohydryl-azetidin-3-yl-)-N-fenyl-metylsulfonamid-derivater
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
CY1112457T1 (el) Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载